No Picture
Los Angeles Biotech News

Jeffrey Hatfield takes over from Diego Miralles as CEO of Vividion; Dragonfly scores a new exec with COO Alex Lugovskoy

Jeffrey Hatfield
→ San Diego protein degradation startup Vividion Therapeutics has made a change at the top with Jeffrey Hatfield taking the helm as CEO, replacing Diego Miralles six months after Roche forked over $135 million to collaborate with Vivid… […]

No Picture
Los Angeles Biotech News

Cerebain Biotech Announces PKG, Inc. to Become Key Manufacturer for ClearMask™ and Xometry

COSTA MESA, Calif.–(BUSINESS WIRE)–Cerebain Biotech Corp. (OTC: CBBT), today announced that PKG, Inc. is to become the key manufacturer for ClearMask, LLC and Xometry. ClearMask™ is the world’s first FDA-cleared, fully transparent surgical mask suita… […]

No Picture
Los Angeles Biotech News

Montrose Environmental Group Announces Pricing of Secondary Offering

IRVINE, Calif.–(BUSINESS WIRE)–(November 24, 2020) – Montrose Environmental Group, Inc. (the “Company” or “Montrose”) (NYSE: MEG) announced today the pricing of the previously announced underwritten secondary offering by certain of the Company’s stoc… […]

No Picture
Los Angeles Biotech News

Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2021 After Market Close on December 2, 2020

TUSTIN, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality develop… […]

No Picture
Los Angeles Biotech News

Urovant Sciences Announces Topline Data from Phase 2a Study of Vibegron for the Treatment of Irritable Bowel Syndrome (IBS) Pain Did Not Meet Primary Endpoint

IRVINE, Calif. & BASEL, Switzerland–(BUSINESS WIRE)–UROV Announces Topline Data from Phase 2a Study of Vibegron for the Treatment of Irritable Bowel Syndrome (IBS) Pain Did Not Meet Primary Endpoint […]

No Picture
Los Angeles Biotech News

Medable gets $91M for virtual clinical trials, bringing total raise to $136M

As biotechs look to get clinical studies back on track amid the pandemic, Medable returned to the venture well for the second time this year, bagging a $91 million Series C to build out its virtual trial platform.
The software provider recently launche… […]